This content is machine translated Sarcoidosis New options from JAKi to mTOR Despite decades of clinical experience, the treatment of sarcoidosis remains a challenge. Although established treatment strategies such as corticosteroids, methotrexate or TNF-alpha blockers are available, the options are limited, particularly...…
View Post 7 min This content is machine translated Treatment of hemophilia New techniques to extend the half-life Prophylactic treatment with factor concentrates is now standard in the treatment of patients with severe hemophilia A. Conventional factor VIII and factor IX concentrates have a relatively short half-life and…
